MARKET

VTRS

VTRS

Viatris Inc Ord Shs
NASDAQ
19.20
+0.43
+2.29%
Pre Market: 19.25 +0.05 +0.28% 08:19 10/30 EDT
OPEN
18.97
PREV CLOSE
18.77
HIGH
19.23
LOW
18.93
VOLUME
364
TURNOVER
--
52 WEEK HIGH
19.23
52 WEEK LOW
9.58
MARKET CAP
22.05B
P/E (TTM)
-53.7665
1D
5D
1M
3M
1Y
5Y
1D
Viatris (VTRS) Stock Looks Undervalued With Sales Support Behind It
Simply Wall St · 21h ago
Is Viatris (VTRS) A Bargain After Its FDA Approval Expanded RYZUMVI Use?
Simply Wall St · 2d ago
Earnings Preview: What to Expect From Viatris' Report
Barchart · 3d ago
Will Presbyopia Approval Change Viatris (VTRS) Narrative
Simply Wall St · 3d ago
Viatris Is Maintained at Neutral by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $14
Benzinga · 4d ago
Viatris price target raised to $14 from $13 at Piper Sandler
TipRanks · 4d ago
Weekly Report: what happened at VTRS last week (1019-1023)?
Weekly Report · 4d ago
More
About VTRS
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.

Webull offers Viatris Inc stock information, including NASDAQ: VTRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTRS stock methods without spending real money on the virtual paper trading platform.